Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;22(4):483-90.
doi: 10.1080/09540120903207292.

Validation of the MOS-HIV as a measure of health-related quality of life in persons living with HIV and liver disease

Wendy A Henderson  1 , Elizabeth A Schlenk, Kevin H Kim, Colleen M Hadigan, Angela C Martino, Susan M Sereika, Judith A Erlen
Affiliations

Validation of the MOS-HIV as a measure of health-related quality of life in persons living with HIV and liver disease

Wendy A Henderson et al. AIDS Care. 2010 Apr.

Abstract

Background: Management of human immunodeficiency virus (HIV) infection with potent antiretroviral medication has transformed HIV into a chronic condition and has shifted much of the burden of disease to co-morbid conditions such as liver disease (LD). LD alone has been shown to have a significant effect on one's health-related quality of life (HRQOL). Clinical evidence suggests that the growing number of persons living with HIV+LD may have a poorer HRQOL than persons with HIV without LD. To date, the widely accepted instrument to assess HRQOL, Medical Outcomes Study-HIV Health Survey (MOS-HIV), has not been evaluated for reliability and validity in a population of HIV-infected persons with LD.

Methods: HRQOL was prospectively assessed using the MOS-HIV in a sample of 532 HIV-infected adults on antiretroviral therapy (n=305 HIV and n=227 HIV+LD). In addition, participants completed standardized questionnaires of sociodemographics and co-morbid conditions.

Results: The psychometric properties of the MOS-HIV were supported by testing reliability and construct, convergent, discriminative, and predictive validity. The MOS-HIV discriminated between those persons living with HIV with and without LD on the basis of the physical function subscale scores (p=0.018).

Conclusion: This study found the MOS-HIV valid and reliable instrument in persons with HIV+LD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no potential conflicts of interest to disclose. None of the authors have an association that might pose a conflict of interest. (more to be added after review)

References

    1. Braitstein P, Montessori V, Chan K, Montaner JSG, Schechter MT, O'Shaughnessy MV, et al. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort. AIDS Care. 2005;17(4):505–515. - PubMed
    1. Buti M, Wong J, Casado MA, Esteban R. Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients. Journal of Hepatology. 2006;44(1 Suppl):S60–S64. - PubMed
    1. Cella DF. Quality of life: The concept. Journal of Palliative Care. 1992;8(3):8–13. - PubMed
    1. Cosby C, Holzemer WL, Henry SB, Portillo CJ. Hematological complications and quality of life in hospitalized AIDS patients. AIDS Patient Care & Stds. 2000;14(5):269–279. - PubMed
    1. Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR, Jr, et al. Health-related quality of life of patients with HIV disease: Impact of hepatitis C coinfection. Clinical Infectious Diseases. 2004;38(4):572–578. - PubMed

Publication types